The objective of this requirement is to acquire interdisciplinary scientific services to support.

Ended Awarded Last action

Contract number
75F40121F19159
Awardee
Awarding agency
Obligated
$1,374,476

Award facts

Contract value 100% obligated
$1,374,476.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 · Closeout MOD -$103,440
Other Administrative Action P00007 · Extend POP $167,927
Other Administrative Action P00006 · Update period of performance at line item level $0
Other Administrative Action P00005 · No cost extension $0
Exercise an Option P00004 · Professional and technical services blanket purchase agreement (BPA) $349,452
Exercise an Option P00003 · Exercise option period 1 $349,452
Other Administrative Action P00002 · No-cost extension to extend the period of performance $0
Other Administrative Action P00001 $0
Original award $611,084

About this award

This federal contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation. The objective of the contract is to acquire interdisciplinary scientific services to support the FDA. The contract, a Blanket Purchase Agreement (BPA) call, has a ceiling value of $1,374,476.15 and a period of performance through August 23, 2024. The contract was awarded under the GSA Multiple Award Schedule (MAS) contract vehicle, which allows federal agencies to procure a wide range of professional and technical services. This award does not have a set-aside designation.

Quick answers

Who was awarded contract 75F40121F19159?

75F40121F19159 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on April 1, 2021.

How much is contract 75F40121F19159 worth?

The government has obligated $1,374,476 on 75F40121F19159.

Is contract 75F40121F19159 an order under another contract?

Yes. 75F40121F19159 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40121F19159 competed?

The extent of competition for 75F40121F19159 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award